Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide | 1451272-71-1 | 98.9% | 341.77 | C13H12ClN3O4S | 100MG
SDP

Catalog No. 5000236291
Encompass_Preferred

SBI-425 is a potent, selective, orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor supplied for research use. It is provided as a high-purity solid with defined molecular properties and is offered in multiple package sizes for laboratory and preclinical studies. Not for human use.

  • Potent and selective TNAP inhibitor.
  • Orally bioavailable suitable for in vivo research.
  • High purity (98.9%).
  • Available in multiple package sizes including 100 mg.
  • Solid powder with molecular weight 341.77 and formula C13H12ClN3O4S.
  • For research use only; not for human therapeutic use.

Catalog No. 50-002-36291 Supplier Medchemexpress LLC Supplier No. HY124756100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SBI-425 is a potent, selective, orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor supplied for research use. It is provided as a high-purity solid with defined molecular properties and is offered in multiple package sizes for laboratory and preclinical studies. Not for human use.

  • Potent and selective TNAP inhibitor.
  • Orally bioavailable suitable for in vivo research.
  • High purity (98.9%).
  • Available in multiple package sizes including 100 mg.
  • Solid powder with molecular weight 341.77 and formula C13H12ClN3O4S.
  • For research use only; not for human therapeutic use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.